Shanghai Titan Scientific Co., Ltd. (SHA:688133)
China · Delayed Price · Currency is CNY 18.98
-0.68 (-3.46%)
Jun 10, 2026, 3:00 PM CST
Shanghai Titan Scientific Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 12.89 | 72.57 | 124.81 | 143.95 |
Depreciation & Amortization | 70.52 | 60.4 | 36.54 | 20.08 |
Other Amortization | 29.34 | 9.45 | 6.67 | 6.06 |
Loss (Gain) From Sale of Assets | -1.88 | -0.72 | - | -0.01 |
Asset Writedown & Restructuring Costs | 0.15 | - | - | 0 |
Loss (Gain) From Sale of Investments | -2.48 | -11.33 | -0.09 | -14.87 |
Provision & Write-off of Bad Debts | 7.96 | 11.42 | 16.22 | 11.04 |
Other Operating Activities | 52.14 | 43.58 | 44.03 | 11.7 |
Change in Accounts Receivable | 136.58 | -182.09 | -145.26 | -360.72 |
Change in Inventory | -81.51 | -142.78 | -268.44 | -319.22 |
Change in Accounts Payable | -41.67 | 6.5 | 2.83 | 239.58 |
Change in Other Net Operating Assets | 11.02 | 9.63 | 34.95 | 24.27 |
Operating Cash Flow | 189.01 | -124.53 | -151.39 | -242.22 |
Capital Expenditures | -480.94 | -464.93 | -299.58 | -135.21 |
Sale of Property, Plant & Equipment | 14.31 | 2.29 | - | 0.01 |
Cash Acquisitions | -31.08 | - | - | -3.95 |
Investment in Securities | -39.51 | -10 | -181.53 | -36.4 |
Other Investing Activities | 0.61 | 1.08 | 0.36 | 5.65 |
Investing Cash Flow | -536.61 | -471.57 | -480.75 | -169.9 |
Long-Term Debt Issued | 1,206 | 828.51 | 741.57 | 431.37 |
Total Debt Issued | 1,206 | 828.51 | 741.57 | 431.37 |
Long-Term Debt Repaid | -903.14 | -567.96 | -378.62 | -225.19 |
Total Debt Repaid | -903.14 | -567.96 | -378.62 | -225.19 |
Net Debt Issued (Repaid) | 303.08 | 260.54 | 362.95 | 206.17 |
Issuance of Common Stock | - | 16.97 | 1,013 | - |
Repurchase of Common Stock | -15 | - | - | - |
Common Dividends Paid | -55.78 | -47.62 | -40.82 | -39.47 |
Dividends Paid | -55.78 | -47.62 | -40.82 | -39.47 |
Other Financing Activities | 68.69 | 14.13 | 16.45 | 39.26 |
Financing Cash Flow | 300.98 | 244.03 | 1,352 | 205.97 |
Foreign Exchange Rate Adjustments | -0.16 | 0.03 | 0.51 | -0.12 |
Net Cash Flow | -46.78 | -352.03 | 720.28 | -206.28 |
Free Cash Flow | -291.93 | -589.46 | -450.97 | -377.43 |
Free Cash Flow Margin | -10.12% | -21.28% | -17.29% | -17.44% |
Free Cash Flow Per Share | -1.81 | -3.60 | -2.91 | -2.53 |
Cash Income Tax Paid | 83.34 | 70.5 | 52.39 | 56.57 |
Levered Free Cash Flow | -406.5 | -655.13 | -653.35 | -290.52 |
Unlevered Free Cash Flow | -380.98 | -637.64 | -636.48 | -284.4 |
Change in Working Capital | 20.37 | -309.9 | -379.57 | -420.17 |